Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Tyce J. Kearl MD, PhD

Tyce J. Kearl MD, PhD profile photo picture

Assistant Professor

Institution: Medical College of Wisconsin
Department: Medicine
Division: Hematology and Oncology - Medicine
Program: Bone Marrow Transplant

image of /images/ORCIDiD_icon16x16.png   https://orcid.org/0000-0002-9255-892X

Member of the Cancer Center
Member of the Center for Immunology


I am willing to collaborate on research projects.


Research Experience

  • Immunotherapy
  • Clinical Expertise

  • Oncologists
  • Methodologies and Techniques

  • Cell Culture Techniques
  • Immune System
  • Sequence Analysis, RNA
  • Single-Cell Analysis
  • Leadership Positions

  • Research Director, BMT and Cell Therapy Laboratory
  • Co-Director, Cell Therapy and Immune Monitoring shared resource laboratory
  • MCW Program / Core Facilities

  • Pediatric Oncology
  • Publications (6)

  • Tumor-specific T cells in head and neck cancer have rescuable functionality and can be identified through single-cell co-culture. (Zenga J, Awan M, Frei A, Foeckler J, Kuehn R, Espinosa OV, Bruening J, Massey B, Wong S, Shreenivas A, Shukla M, Kasprzak J, Sun Y, Shaheduzzaman M, Chen F, Kearl T, Himburg HA) Transl Oncol 2024 Apr;42:101899 PMID: 38320395 PMCID: PMC10851216 SCOPUS ID: 2-s2.0-85184507548 02/07/2024    
  • Corrigendum to Tumor-specific T cells in head and neck cancer have rescuable functionality and can be identified through single-cell co-culture (Translational Oncology (2024) 42, (S1936523324000251), (10.1016/j.tranon.2024.101899)) (Zenga J, Awan M, Frei A, Foeckler J, Kuehn R, Espinosa OV, Bruening J, Massey B, Wong S, Shreenivas A, Shukla M, Kasprzak J, Sun Y, Shaheduzzaman M, Chen F, Kearl T, Himburg HA) Translational Oncology 2024 SCOPUS ID: 2-s2.0-85187349354 01/01/2024    
  • Controlling Cytokine Release Syndrome to Harness the Full Potential of CAR-Based Cellular Therapy. (Thakar MS, Kearl TJ, Malarkannan S) Front Oncol 2019;9:1529 PMID: 32076597 PMCID: PMC7006459 SCOPUS ID: 2-s2.0-85079671509 02/23/2020       22 Citations
  • Programmed death receptor-1/programmed death receptor ligand-1 blockade after transient lymphodepletion to treat myeloma. (Kearl TJ, Jing W, Gershan JA, Johnson BD) J Immunol 2013 Jun 01;190(11):5620-8 PMID: 23616570 PMCID: PMC3891840 SCOPUS ID: 2-s2.0-84878099006 04/26/2013       83 Citations
  • Phosphatidylethanolamine is externalized at the surface of microparticles. (Larson MC, Woodliff JE, Hillery CA, Kearl TJ, Zhao M) Biochim Biophys Acta 2012 Dec;1821(12):1501-7 PMID: 22960380 PMCID: PMC3809829 SCOPUS ID: 2-s2.0-84866500244 09/11/2012       50 Citations
  • Methods for studying voltage-gated sodium channels in heterologous expression systems. (Dice MS, Kearl T, Ruben PC) Methods Mol Med 2006;129:163-85 PMID: 17085811 SCOPUS ID: 2-s2.0-35548949165 11/07/2006       3 Citations
  • Last update: 04/16/2024